MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein. - Wikidata - wikimedia - TriplyDB

MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein.

MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein.

http://www.wikidata.org/entity/Q36525872

about

Leucine-rich repeat kinase 2 regulates Sec16A at ER exit sites to allow ER-Golgi export microRNAs: Emerging Targets Regulating Oxidative Stress in the Models of Parkinson's Disease MicroRNAs: Key Regulators in the Central Nervous System and Their Implication in Neurological Diseases The involvement of microRNAs in neurodegenerative diseases Neuronal dark matter: the emerging role of microRNAs in neurodegeneration Epigenetic landscape of Parkinson's disease: emerging role in disease mechanisms and therapeutic modalities A Proteomics Approach to Investigate miR-153-3p and miR-205-5p Targets in Neuroblastoma Cells Protective LRRK2 R1398H Variant Enhances GTPase and Wnt Signaling Activity.Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy.Parkinson's disease-implicated kinases in the brain; insights into disease pathogenesis.RNA metabolism in the pathogenesis of Parkinson׳s disease Expression analysis of Lrrk1, Lrrk2 and Lrrk2 splice variants in mice.Midbrain dopamine neurons in Parkinson's disease exhibit a dysregulated miRNA and target-gene network MicroRNA‑205 promotes the tumorigenesis of nasopharyngeal carcinoma through targeting tumor protein p53-inducible nuclear protein 1.Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease Genotype and age at Parkinson disease diagnosis.Computational Prediction of Alzheimer's and Parkinson's Disease MicroRNAs in Domestic Animals LRRK2: an éminence grise of Wnt-mediated neurogenesis?RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis.LRRK2: cause, risk, and mechanism.MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B Identification of therapeutic targets for Parkinson's disease via bioinformatics analysis.Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases.MicroRNA-205 suppresses the oral carcinoma oncogenic activity via down-regulation of Axin-2 in KB human oral cancer cell.Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders.MicroRNA machinery in Parkinson's disease: a platform for neurodegenerative diseases.microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases.microRNAs and Neurodegenerative Diseases.MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?Epigenetic mechanisms in neurogenesis.Epigenetic regulation in Parkinson's disease.Molecular changes in the postmortem parkinsonian brain.MicroRNAs in glaucoma and neurodegenerative diseases.The roles of non-coding RNAs in Parkinson's disease.Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting.miRNAs as biomarkers of neurodegenerative disorders.LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies.miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1).

P2860

Q24303851-918C0587-7A90-4A9E-9346-09146078EFA4 Q26738440-76B0535F-8D63-404B-A7D0-D356A97D563A Q26744819-4F577BD4-B1F3-45F7-9635-3AD404A6C62B Q26858788-112165AC-D94B-4A07-8D58-6BF8B7889E4E Q26859224-FE8BBCDB-0F1B-4659-B907-9046623B5949 Q27023811-52FE4E31-9D8B-4A77-B578-837D16D365D7 Q28551285-96D648B7-9DF5-4EC1-B279-5E7946C264CE Q29347547-56313840-7B53-46DC-AA95-B4B3294C4414 Q33567669-C153B0AE-DA5C-4FB6-95DE-088686325C3B Q33732095-AFB963EF-AE68-41AE-BB07-E07C8F20BBD7 Q33797449-95FF4653-16E5-4422-837A-9D9CC3ED19DF Q34175642-DB813BCF-1C8C-41F4-8BD3-3E960FED0BC3 Q34723024-EB054C4D-8038-4C9C-B161-8BE4C6E0D08D Q35654904-A848E700-426E-4392-977E-C87706413BF9 Q36089751-B37A9281-37D6-4FA6-B8B0-60F0F4ADC484 Q36545671-0E737F48-E413-4D9D-8C88-63882EDF34BD Q36729049-5CF632F0-12E4-405B-903C-3724B0F21E51 Q36855169-4B69D343-92B5-469B-A2DA-9DE2A7A88FA4 Q36888947-516C49AD-76DB-4FB7-9C33-5D38D32221D4 Q37325908-6D8915AD-799E-4027-8841-B679370858B6 Q37635000-4FCEFA08-827D-4D84-8CB0-64B956A3B248 Q37702119-B5BA02BE-838B-4FFE-8635-D606CFB8F870 Q37707469-8459DFE1-98C8-4DBC-AF5D-F2DD7DB84B94 Q37720038-127675DF-6856-4693-B3AD-B30FFF057E65 Q38224066-22E42B1C-D66B-4907-9924-5F7A01FA04B0 Q38445454-13493F61-C570-4FB0-B5FD-F8BC39635321 Q38584755-9AA9B2F2-EC73-4585-BB33-572C76370E73 Q38635154-1A0D7C9B-A9DE-4684-B217-A78D38F85DDB Q38648154-7C255713-2E11-4DF7-B46C-65E02E634EA0 Q38668251-6F3346BA-E28B-47E7-A1F3-16393095042B Q38843644-9C13871E-1AF7-4BEA-9BB7-11679EAEBEA2 Q38873613-A1CA675E-C29A-4780-B2D2-ACA2A6E3E435 Q38881221-F1E11D29-BE5B-409F-AD8E-E17B09700303 Q38887346-5DC4B252-0509-46C9-8C60-91AD41FA4E8D Q38895922-2D995A42-A951-4321-97F3-E92A7F8F9F9F Q38918848-EA98FF5D-AE25-4A5C-836D-3F4144962BFD Q39010887-474837C7-D0AA-4227-A21D-3F58055C0DE6 Q39104808-F75876CD-1C13-49C1-8925-5E3CD5BCE4E8 Q39136594-92766C14-8B03-4A20-BE15-B1FA716BC873 Q39561853-C88CA0AE-7136-4E39-9890-95CD6555C992

P2860

MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein.

http://www.wikidata.org/entity/Q36525872

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

MicroRNA-205 regulates the exp ...... -rich repeat kinase 2 protein.

@ast

MicroRNA-205 regulates the exp ...... -rich repeat kinase 2 protein.

@en

type

label

MicroRNA-205 regulates the exp ...... -rich repeat kinase 2 protein.

@ast

MicroRNA-205 regulates the exp ...... -rich repeat kinase 2 protein.

@en

prefLabel

MicroRNA-205 regulates the exp ...... -rich repeat kinase 2 protein.

@ast

MicroRNA-205 regulates the exp ...... -rich repeat kinase 2 protein.

@en

P1433

Q36525872-DF2CEE5C-8C04-4B2F-AC5A-F3FDDE7FC09C

P1476

Q36525872-68C78ABC-4C75-419B-B425-9EEDB59B4F06

P2093

Q36525872-1330FA03-2F18-4097-A258-CE75219E2813

Q36525872-360E9A6A-CE08-4082-B44F-684BFAC740D2

Q36525872-56CCBF58-B4AB-4D51-8E07-44DFA763C08F

Q36525872-6F5F52DD-71AE-4643-8C25-2437B0B4FD4E

Q36525872-77E8EF65-9E90-41A4-910A-1592FEDD87AB

Q36525872-890A0BC7-57CD-47EF-8CDF-5F910B77AA4A

Q36525872-9B61C291-3273-4B37-A17B-141CC7081E9D

Q36525872-A54DF1D9-A567-4080-9D59-5C166D7E7BCF

Q36525872-A5F490DD-EE83-442B-BEB4-EF30CDE82231

Q36525872-B7353AC9-528B-4E64-BA66-77C7F6AEEB70

P2860

Q36525872-00CE2635-8CF9-4705-BDEF-F35C1340B0C0

Q36525872-00F4943B-50DA-48D3-8C88-CF7DC744A9AC

Q36525872-0F9E7E19-EE21-41B3-BC2E-A87C507F412E

Q36525872-12338FF0-ADA1-4952-9EC0-DC19734583D7

Q36525872-14206E2E-EA79-4DB0-8221-1CF2302B7B43

Q36525872-14EC6519-BDE8-4782-9ED7-D1FF777DF8DF

Q36525872-1C05CA4B-78B4-4D4F-BFE0-AB4CA27CDD2F

Q36525872-2AC0816E-DD5F-456A-A6DD-7C8E2BA14A0E

Q36525872-3EF0086D-22EB-4542-83C9-E6586B76897B

Q36525872-4103B0BD-D04A-4D18-8E46-1E4ECC857C2A

P304

Q36525872-47B07BF7-21A2-4E39-A768-52327A8D7DC1

P31

Q36525872-8DCF9F36-3602-4F1E-8315-CCB9E9D933F1

P356

Q36525872-59CDC3C9-77F0-4F0D-AE14-A92AE31AA267

P433

Q36525872-D9BF28B5-1D49-4B7A-A84F-780ECDADF072

P478

Q36525872-3DAAB53B-49ED-49F9-8AA3-46A8136774A5

P50

Q36525872-12A7D96A-A3CE-47F9-8ED4-A6132E4B350E

Q36525872-671F92B1-06AF-4E34-A748-D3C2289E85EE

Q36525872-9288A4DF-0C31-4DF4-83C7-7302D74B9776

Q36525872-A4BE3BD8-802E-4048-B858-659770301E17

P577

Q36525872-D6AE134B-F2A7-4F18-90F7-052FC69D9EF6

P5875

Q36525872-638D4F16-BFDA-4AEB-93B1-F0E1795F3FE1

P698

Q36525872-71DA64D5-BE86-444A-AE24-DE4983ABDE15

P921

Q36525872-74208757-20A0-4040-B576-2BE06D6E9A23

Q36525872-B5763EA2-6BEC-4E05-91CF-2FDA53E5CB8B

P932

Q36525872-F6276D68-6D08-432A-9556-E9A71B2CDAB4

P356

P1433

Human Molecular Genetics

P1476

MicroRNA-205 regulates the exp ...... e-rich repeat kinase 2 protein

@en

P2093

Chengsong Xie

http://www.w3.org/2001/XMLSchema#string

Guoxiang Liu

http://www.w3.org/2001/XMLSchema#string

Hyun Jin Cho

http://www.w3.org/2001/XMLSchema#string

Jia Yu

http://www.w3.org/2001/XMLSchema#string

Jinhui Ding

http://www.w3.org/2001/XMLSchema#string

Juan C Troncoso

http://www.w3.org/2001/XMLSchema#string

Lixin Sun

http://www.w3.org/2001/XMLSchema#string

Loukia Parisiadou

http://www.w3.org/2001/XMLSchema#string

Ping He

http://www.w3.org/2001/XMLSchema#string

Renée Vancraenenbroeck

http://www.w3.org/2001/XMLSchema#string

P2860

Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression

TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing

LRRK2 expression in idiopathic and G2019S positive Parkinson's disease subjects: a morphological and quantitative study

MicroRNAs: target recognition and regulatory functions

Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs

Genome-wide association study reveals genetic risk underlying Parkinson's disease

MicroRNA-205 inhibits tumor cell migration through down-regulating the expression of the LDL receptor-related protein 1

Detection of metastatic head and neck squamous cell carcinoma using the relative expression of tissue-specific mir-205

Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis

Prediction of mammalian microRNA targets

P304

608-620

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HMG/DDS470

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Marc Taymans

P577

2012-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232813830

http://www.w3.org/2001/XMLSchema#string

P698

23125283

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

3542867

http://www.w3.org/2001/XMLSchema#string